June Herling

June Herling possesses extensive experience in quality management within the biopharmaceutical and healthcare sectors. Currently serving as Executive Director and Quality Site Head at Bristol Myers Squibb since September 2021, June has previously held positions including Sr. Director and Director within the Quality Cell Therapy domain. Prior to Bristol Myers Squibb, June spent over four years at Novartis in various quality leadership roles, including Site Quality Head. June's career began at Mannatech Incorporated and Neos Therapeutics, Inc., with responsibilities encompassing quality assurance and compliance. Educational qualifications include a Master of Science and Bachelor of Science in Biology from the University of Texas at Arlington.